Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Continuing Tenofovir Versus Switching Entecavir to Tenofovir in Chronic Hepatitis B
TCTR20160125002Phase 3Active, not recruiting
- Sponsor
- Chulabhorn Hospital
- Start
- Jan 2016
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of tenofovir in Chronic Hepatitis B (CHB), sponsored by Chulabhorn Hospital. Started Jan 2016; status: active, not recruiting.
02
Drugs
tenofovir
03
Conditions
Chronic Hepatitis B (CHB)
Beyond the preview
Go deeper on TCTR20160125002.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on TCTR20160125002.